GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Firebrick Pharma Ltd (ASX:FRE) » Definitions » PB Ratio

Firebrick Pharma (ASX:FRE) PB Ratio : 11.93 (As of Apr. 08, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Firebrick Pharma PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-04-08), Firebrick Pharma's share price is A$0.0835. Firebrick Pharma's Book Value per Share for the quarter that ended in Dec. 2024 was A$0.01. Hence, Firebrick Pharma's PB Ratio of today is 11.93.

The historical rank and industry rank for Firebrick Pharma's PB Ratio or its related term are showing as below:

ASX:FRE' s PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 13.14
Current: 13.14

During the past 4 years, Firebrick Pharma's highest PB Ratio was 13.14. The lowest was 0.00. And the median was 0.00.

ASX:FRE's PB Ratio is ranked worse than
95.09% of 936 companies
in the Drug Manufacturers industry
Industry Median: 1.775 vs ASX:FRE: 13.14

During the past 12 months, Firebrick Pharma's average Book Value Per Share Growth Rate was -22.20% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -45.50% per year.

During the past 4 years, the highest 3-Year average Book Value Per Share Growth Rate of Firebrick Pharma was -45.50% per year. The lowest was -45.50% per year. And the median was -45.50% per year.

Back to Basics: PB Ratio


Firebrick Pharma PB Ratio Historical Data

The historical data trend for Firebrick Pharma's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Firebrick Pharma PB Ratio Chart

Firebrick Pharma Annual Data
Trend Jun21 Jun22 Jun23 Jun24
PB Ratio
- 5.41 11.07 5.09

Firebrick Pharma Semi-Annual Data
Jun21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
PB Ratio Get a 7-Day Free Trial 7.67 11.07 5.56 5.09 8.86

Competitive Comparison of Firebrick Pharma's PB Ratio

For the Drug Manufacturers - General subindustry, Firebrick Pharma's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Firebrick Pharma's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Firebrick Pharma's PB Ratio distribution charts can be found below:

* The bar in red indicates where Firebrick Pharma's PB Ratio falls into.


;
;

Firebrick Pharma PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Firebrick Pharma's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2024)
=0.0835/0.007
=11.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Firebrick Pharma  (ASX:FRE) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Firebrick Pharma PB Ratio Related Terms

Thank you for viewing the detailed overview of Firebrick Pharma's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Firebrick Pharma Business Description

Traded in Other Exchanges
N/A
Address
440 Collins Street, Level 10, Melbourne, VIC, AUS, 3000
Firebrick Pharma Ltd is an Australian pharmaceutical developer. It is engaged in the development and commercialization of povidone-iodine (PVP-I) products under the Nasodine brand. Its Nasodine Nasal Spray which is in the commercialization phase, is a broad-spectrum anti-viral spray, designed to be an effective treatment and prevention of respiratory viral infections such as the common cold. In parallel, the company is also engaged in the development of the follow-on Nasodine brand products.

Firebrick Pharma Headlines

No Headlines